The Federal Trade Commission (FTC) recently sued the three largest pharmacy benefit managers (PBMs) – Caremark Rx, Express Scripts (ESI) and OptumRx ...
CVS Health, one of the biggest players in the battle to acquire physicians, is facing a possible split amid major financial struggles. In 2023, CVS Health spent $10.6 billion to acquire primary care ...
Attorneys argue Khan and two other commissioners are biased against pharmacy benefit managers and should recuse themselves ...
Court of Chancery rejects Plaintiffs’ claims that directors engaged in “affirmative lawbreaking for profit”, finding alleged ...
A federal antitrust watchdog is already conducting an investigation into and has filed a lawsuit against huge pharmacy ...
CVS Health (CVS – Research Report) received a Buy rating and an $82.00 price target from Barclays analyst Andrew Mok CFA today. The ...
A federal antitrust watchdog is conducting an investigation into, and has filed suit against, huge pharmacy middlemen. Two ...
A growing number of companies, including CVS, Home Depot and Walmart, have already announced plans to help victims impacted ...
UnitedHealth, CVS Health, and Cigna have petitioned a judge to sideline FTC Chair Lina Khan from the agency’s lawsuit against ...
A federal antitrust watchdog is already conducting an investigation into and has filed a lawsuit against huge pharmacy ...
Axios Vitals on MSN8h
Mark Cuban takes his PBM fight to employersThe latest calls to revamp the prescription drug market and lower prices are coming from billionaire Mark Cuban, who's urging ...
CVS is reportedly conducting a strategic review and weighing options for separating some of the company’s businesses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback